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The expression level of acute phase proteins (APPs) mirrors the health status of an
individual. In human medicine, C-reactive protein (CRP), and other members of the
pentraxin family are of significant relevance for assessing disease severity and prognosis.
In chickens, however, which represent the most common livestock species around the
world, no such marker has yet gained general acceptance. The aim of this study was
therefore, to characterize chicken pentraxin 3 (chPTX3) and to evaluate its applicability as
a general marker for inflammatory conditions. Themammalian and chicken PTX3 proteins
were predicted to be similar in sequence, domain organization and polymeric structure.
Nevertheless, some characteristics like certain sequence sections, which have varied
during the evolution of mammals, and species-specific glycosylation patterns, suggest
distinct biological functions. ChPTX3 is constitutively expressed in various tissues but,
interestingly, could not be found in splenic tissue samples without stimulation. However,
upon treatment with lipopolysaccharide (LPS), PTX3 expression in chicken spleens
increased to 95-fold within hours. A search for PTX3 reads in various publicly available
RNA-seq data sets of chicken spleen and bursa of Fabricius also showed that PTX3
expression increases within days after experimental infection with viral and bacterial
pathogens. An experimental infection with avian pathogenic E.coli and qPCR analysis of
spleen samples further established a challenge dose-dependent significant up-regulation
of chPTX3 in subclinically infected birds of up to over 150-fold as compared to untreated
controls. Our results indicate the potential of chPTX3 as an APP marker to monitor
inflammatory conditions in poultry flocks.
Keywords: chicken, pentraxin, acute phase proteins, inflammation, next generation sequencing, LPS, avian
pathogenic E. coli
INTRODUCTION
The poultry industry is a fast-growing and intensive branch of the food economy and it is likely
to gain even more relevance in the future. This development is due to the chickens’ extraordinarily
good feed conversion ratio and their lowmethane and carbon dioxide production (1), which makes
chickens a financially rewarding and environmentally sound meat source. To further maintain
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chicken health, parameters indicating pathological conditions
before they are clinically visible are highly demanded, but no
valuable marker for general inflammation in chickens has been
established so far.
Potential candidates for suchmarkersmay be foundwithin the
class of the acute phase proteins (APPs) (2). APPs are positively
or negatively regulated during the acute phase response (APR)
as a reaction to proinflammatory cytokine secretion shortly after
impact of inflammatory stimuli and represent an unspecific
immune reaction (3, 4). They are classified as major (>10-fold),
moderate (4 to 10-fold), or minor APPs (2 to 3-fold) according to
their fold increase after application of an inflammatory stimulus
(5). An increased expression of APPs, especially of members
of the pentraxin family, has previously been associated with
a variety of pathological conditions like cancer (6), acute and
chronic inflammatory disease (7–9) and psychosocial stress (10)
in mammals. C-reactive protein (CRP), which was discovered in
1930 (11), is among the most important markers for the severity
of inflammatory diseases in clinical human medicine (12).
There is a growing body of information concerning the acute
phase response in chickens. The most commonly examined
chicken APPs are ceruloplasmin, ovotransferrin, and α1-acid
glycoprotein (13–15). They are classified as moderate APPs
(5). Ceruloplasmin and ovotransferrin are both important
antioxidants. Ceruloplasmin catalyzes the oxidation of Fe2+
and thereby prevents the formation of free radicals (16).
Ovotransferrin binds Fe3+ and its high affinity for this ion
provides protection against iron-catalyzed free radical formation
and also inhibits bacterial growth (17). α1-acid glycoprotein
is a pH-dependent, unspecific carrier of lipophilic compounds,
which is most effective in a basic or neutral environment (18).
Surprisingly, most acute phase markers established in human
medicine are classified only as minor or moderate APPs in
chickens (5). CRP and mannose-binding lectin (MBL), for
example, two of the major mammalian APPs, have been found to
increase expression only around 2-fold in response to Ascaridia
galli infestation (19). MBL is also weakly up-regulated in serum
at 3 days post infection with IBV (20), 2 days after inoculation of
E.coli (21), and 16 h after LPS challenge (22). However, a variable
genetic background of chicken lines and individuals, that strongly
influences the constitutive expression of MBL, has been found
(23), indicating that the value of MBL—and therefore also of
other minor and moderate APPs—as marker proteins must be
considered carefully. The investigation of major chicken acute
phase proteins hence is crucial for establishing a general health
marker for this species.
SAA, which is in humans known to be up-regulated in
osteoarthritis and might potentially contribute to the formation
of the disease (24), has been investigated in chickens and is
Abbreviations: APEC, Avian Pathogenic E. coli; APP, acute phase protein; APR,
acute phase response; CFU, colony forming units; chPTX3, chicken Pentraxin 3;
CRP, C-reactive Protein; CTR, control; dpi, days post infection; GaHV2, Gallid
Alphaherpesvirus 2; hpi, hours post infection; IBDV, Infectious Bursal Disease
Virus; LPS, lipopolysaccharide from E. coli; MBL, mannose-binding lectin; MW,
molecular weight; NGS, next generation sequencing; RIN, RNA integrity number;
RPKM, reads per kilobase per million mapped reads; SAA, serum amyloid A; SAP,
serum amyloid P; SRA, sequence read archive.
classified as the only major APP in this species so far (5). It was
found that SAA serum concentrations increase strongly 24 to 48 h
after Enterococcus faecalis injection (25) and other stimuli (26).
More recent studies, however, revealed a less pronounced up-
regulation of SAA after infection with IBDV and IBV (27, 28)
and thereby object its classification as a major APP.
Among other APPs, such as haptoglobin, complement C3
and α2-macroglobulin, members of the pentraxin family are of
particular relevance during the human APR (29–31). Pentraxin
family members are characterized by a C-terminal pentraxin
domain, which contains the eight amino acid pentraxin signature
motif. This short sequence is highly conserved among pentraxins.
While the so-called short pentraxins, like the classical APPs CRP
and Serum amyloid P (SAP), consist solely of the pentraxin
domain, the long family members like Pentraxin 3 (PTX3)
possess a second, N-terminal domain (32). As the cysteine
residues C47, C49, and C103 within the N-terminal domain of
human PTX3 form interchain disulfide bridges (33), quaternary
structures of the prototypic short and long pentraxins vary due to
the missing N-terminal domain in short pentraxins (32). Human
PTX3 forms asymmetric, cyclic octamers (33).
PTX3 has been studied intensively in mice and humans,
revealing its multiple roles in immunity. It contributes to
prevention of bacterial (34), viral (35), and fungal (36)
infections and is associated with autoimmune diseases, such
as systemic lupus erythematosus, ankylosing spondylitis and
multiple sclerosis (37). Despite the magnitude of information
concerning structure, function, and expression patterns of
mammalian PTX3, the chicken equivalent has been neglected to
date. Interestingly, our group recently found PTX3 to be strongly
induced in chickens after IFN-α application. It became evident
that, compared to control animals, PTX3 expression in spleens of
birds that have been injected with this cytokine increased 685-
fold 3 h after injection, whereas CRP was not detected at all
(38). This massive increase in PTX3 expression after immune
stimulation indicates the potential relevance of PTX3 among
APPs in chickens.
In this study, we investigate the predicted protein structure of
chPTX3 and its expression patterns under non-inflammatory and
inflammatory conditions and thereby evaluate its importance as
a general marker for inflammatory conditions in birds.
MATERIALS AND METHODS
Sequence Alignment, Phylogenetic
Analysis, and Prediction of Protein
Characteristics
Species-specific PTX3 sequences were obtained
from Ensemble (https://www.ensembl.org/; human:
ENST00000295927.3; mouse: ENSMUST00000029421.5; bovine:
ENSBTAT00000011863.4; porcine: ENSSSCT00000012837.4;
chicken: ENSGALT00000045711.2; frog:
ENSXETT00000026752.2; zebra fish: ENSDART00000112933.3).
Sanger-sequencing of PCR products for alignment was
commissioned to GATC Biotech AG, Konstanz, Germany.
The sequences were aligned via ClustalX2 (http://www.clustal.
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org) and further edited with GeneDoc2.7 (http://genedoc.
software.informer.com). Sequence similarities and identities
were calculated using LALIGN by ExPasy (http://embnet.
vital-it.ch/software/LALIGN_form.html). N-glycosylation sites
were predicted using the NetNGlyc 1.0 Server (http://www.
cbs.dtu.dk/services/NetNGlyc/). For phylogenetic analysis,
protein sequences of the above mentioned species-specific PTX3
transcripts were obtained from ensemble and aligned via Muscle
Alignment in MEGA (https://www.megasoftware.net/). The
resulting alignment was used to create a maximum likelihood
tree using 1,000 bootstraps and complete deletion of missing
data. Otherwise, default settings were used. Molecular weight
prediction was executed using ExPasy (https://web.expasy.org/
compute_pi/).
Expression of Recombinant chPTX3
The cDNA sequence of chPTX3 was amplified using full length
primers (sense: 5′ TTACAAGGATGACGATGACAAGCTTTCC
GTGCTGGATGAAGGC 3′; antisense: 5′ CTGAGATGAGTTT
TTGTTCTCTAGATTAAGAAACATACTGAGCTCCTCCATAT
AG 3′; manufactured by Eurofins Scientific, Hamburg,
Germany) and Phusion R© DNA polymerase (Thermo Fisher
Scientific, Waltham, MA, USA) according to the manufacturers’
instructions. As a template, cDNA transcribed fromRNA isolated
from the spleen of a chicken injected with lipopolysaccharide
from Salmonella enterica serovar Typhimurium (LPS) (see
section Treatment of Chickens With LPS) was used. The
obtained sequence was cloned into p3xFlag-Myc-CMV-25
(Sigma-Aldrich, Taufkirchen, Germany) with the NEBuilder
Assembly Kit (New England Biolabs, Frankfurt a.M., Germany)
according to the manufacturer’s instructions. HEK293 cells were
stably transfected with the construct p3xFlag-Myc-CMV-25-
chPTX3 using X-tremeGENE 9 DNA Transfection ReagentTM
(Sigma-Aldrich, Taufkirchen, Germany) according to the
manufacturer’s instructions. After transfection, 0.25mg G418
per ml medium was added for clonal selection after every
third cell passage. The resulting recombinant protein carries an
N-terminal 3x FLAG tag.
Purification of Recombinant chPTX3
Recombinant chPTX3 was purified from supernatant of stably
transfected HEK293 cells using a Glass Econo-Column R© (Bio-
Rad Laboratories, Munich, Germany) packed with ANTI-
FLAG R©M2Affinity Gel (Sigma-Aldrich, Taufkirchen, Germany)
and eluted from the gel matrix with 0.1M glycin-HCl pH 3.5. The
pH of the purified protein was neutralized by addition of 30 µl
1M tris-HCl pH 8.0 per ml eluate.
Western Blot
After SDS-polyacrylamide gel electrophoresis, Western
blot analysis was carried out as described elsewhere (39).
Purified recombinant chPTX3 protein was visualized by
anti-Flag immunostaining (mouseIgG1 anti-Flag (M2)-
HRP; Sigma-Aldrich, St. Louis, MO, USA) and subsequent
chemiluminescence. Reducing conditions were established
by addition of a final concentration of 25mM Dithiothreitol
(Applichem, Darmstadt, Germany) to the samples before
electrophoresis. Deglycosylation was carried out by incubation
with PNGaseF (New England Biolabs, Frankfurt a.M., Germany),
according to the manufacturer’s protocol.
Analysis of Publicly Available RNA-Seq
Data
The chPTX3 nucleotide sequence was used as a query in BLAST
searches against Short Read Archive (SRA) files obtained from
NCBI (https://www.ncbi.nlm.nih.gov/sra/) using an expected
threshold of 1e-10, a word size of 7 and the highest possible
number for maximum target sequences. The number of hits
was put at a ratio to query size and file size, resulting in a
calculated estimate of gene expression (reads per kilobase per
million mapped reads; RPKM).
Chickens
Treatment of Chickens With LPS
Six-week-old Lohmann Selected Leghorn chickens (Gut
Heinrichsruh, Berglern, Germany), vaccinated only against
Marek’s disease, were conventionally housed for 5 days prior to
the experiment. Water and a commercial diet were provided ad
libitum. On the day of the experiment, chickens were randomly
divided into two groups of six, of which one group was injected
intravenously with 10 µg LPS from S. Typhimurium (Sigma-
Aldrich, Taufkirchen, Germany; L6511) per kg body weight
in 100 µl PBS (LPS) while the other group received PBS only
(CTR). Three hours after injection, all animals were euthanized
and tissue samples were collected. Animal experiments were
approved by the Government of Upper Bavaria, License number
55.2-1-54-2531-121-09.
Experimental Infection With APEC O1
Chickens of the inbred line 72 (B
2) were hatched and reared
under specified pathogen-free conditions with ad libitum access
to feed and water. At the age of 2 weeks, the birds were
inoculated with 7.3 × 104 colony forming units (CFU), 1.1 ×
106 CFU or 8.8 × 106 CFU APEC serotype O1:K1:H7 strain
O1 (40) (gratefully received from Prof Lisa Nolan, Iowa State
University, USA) in 100 µl PBS or with 100 µl PBS as control
administered into the right thoracic air sac. APEC O1 inoculated
birds (N = 6 per inoculation dose) and control birds (N = 3)
were culled at 14 hours post infection (hpi), 3 days post infection
(dpi) or 7 dpi. All birds were housed in premises licensed
under UK Home Office Establishment Licenses (X212DDDBD
and XA40CEF03) in full compliance with the requirements of
the Animals (Scientific Procedures) Act 1986. Procedures were
conducted under license PPL 60/4420 with the consent of The
Moredun Research Institute Ethical Review Committee.
Tissue Sampling
Tissue samples used for this study were collected immediately
after euthanasia of the animals and either kept in ice cold sterile
PBS for immediate RNA preparation or transferred to autoclaved
1.5ml snap-cap cups and snap frozen in liquid nitrogen.
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Enumeration of Viable Bacteria
Spleen samples were collected in tubes with 500 µl sterile PBS
and weighed. The tissues were homogenized using a TissueLyser
II (Qiagen, Manchester, UK), ten-fold serial dilutions in PBS
prepared and 100 µl plated onto antibiotic free MacConkey agar
plates (Oxoid, Basingstoke, UK). The plates were incubated at
37◦C overnight before E. coli colonies were counted to calculate
the number of colony-forming units (CFU)/g of tissue.
RNA Preparation
RNA of chicken tissue samples was isolated with TriFast reagent
(Peqlab, Erlangen, Germany) according to the manufacturer’s
instructions. RNA quality was determined using a Bioanalyzer
(Agilent, Santa Clara, CA, USA); only RNA with a minimum
RNA integrity number (RIN) of 8.0 was used for further analyses.
cDNA Synthesis
A total of 1 µg RNA per sample was digested by DNAse I
(Thermo Fisher Scientific, Waltham, MA, USA) for 30min at
37◦C. DNAse I was inactivated by addition of 2.5mM EDTA
and incubation at 65◦C for 10min. 400 ng of the DNA-free RNA
was subsequently transcribed into cDNA using the GOScript kit
(Promega, Madison, WI, USA) according to the manufacturer’s
protocol.
PCR
PCR analysis was performed using Taq-Polymerase (Solis
BioDyne, Tartu, Estonia) and respective buffers according to the
manufacturer’s instructions, and cDNA of the samples of interest
as a template. For analysis of chPTX3 expression in lymphoid
tissues, primers spanning the adjoining region of the pentraxin
domain at the C-terminus and the N-terminal domain were
used to avoid potential amplification of short pentraxins (sense:
5′ ACCAACCTGAGGATGCTG 3′; antisense: 5′ CCGTAGGAG
AAGATGATGGTT 3′) at an annealing temperature of 49◦C and
an extension time of 30 sec. GAPDH expression (Primer sense:
5′ CACGGACACTTCAAGGGCACTG 3′; primer antisense: 5′
CTCCACAATGCCAAAGTTGTC 3′; annealing temperature:
50◦C; extension time: 20 sec) was used for normalization. After
34 cycles, PCR products were mixed with one sixth volume of 6x
loading buffer with GelRed (GenScript Biotech, Piscataway, NJ,
USA) and loaded on a 1.2% agarose gel in TBE buffer (90mM
tris, 90mM boric acid, 2mM EDTA-Na2, pH 8.0). After voltage
application of 130V for 25min, resulting bands were visualized
under ultravoilet light.
RNA-seq Analysis
mRNA libraries were prepared from 1 ng RNA from five
LPS-treated spleens and five spleens of mock-treated chickens
each, using the Sense mRNA Seq Library Kit V2 (Lexogen,
Vienna, Austria) according to the manufacturer’s instructions.
Next-generation sequencing (NGS) was performed on the
Illumina HiSeq 1,500 Platform (Illumina, Munich, Germany),
producing single-end 100 bp reads (Gene Center, Laboratory
for Functional Genome Analysis, LMU Munich, Germany).
Read filtering, de novo assembly, and alignment to the galGal4
chicken genome was performed in Galaxy (https://usegalaxy.
org/) as described elsewhere (41). FASTA files containing the
aligned data were created. Only genes with a minimum 4-
fold expression change between groups and an adjusted p-value
of <0.001 were included in further analysis. The home-made
scripts used for detailed analysis workflow are available upon
request.
Quantitative RT-PCR
SYBR Green-based quantitative RT-PCR (qPCR) was performed
with cDNA as a template, using GoTaq qPCR Master Mix
(Promega, Madison, WI, USA) according to the manufacturer’s
instructions with a final concentration of 1x of a chicken PTX3-
specific commercial QuantiTect Primer Assay (Qiagen, Hilden,
Germany) or 300 nM each of GAPDH primers (Primer sense:
5′ AGGGTGGTGCTAAGCGTGTT 3′; primer antisense: 5′
AAGGGTGCCAGGCAGTTG 3′), respectively. Primer efficiency
was determined using serial dilutions of a cDNA mix and
was 96% for PTX3 and 93% for GAPDH. In addition to
the primers, each 25 µl reaction contained 12.5 µl of the
GoTaq qPCR Master Mix, 0.25 µl 100x CXR Reference Dye,
4.25 µl of nuclease-free water, and 5 µl of cDNA (10 ng).
The cycling conditions were set to 95◦C/2min, followed by
40 cycles of 95◦C/15 s, 59 (GAPDH) or 56◦C (PTX3)/30 s,
72◦C/30 s. Each assay included relevant non-template controls.
A melting curve performed following each run confirmed a
single, specific PCR product. Raw data created by a 7,300 Real-
Time PCR System R© (Applied Biosystems, Foster City, CA,
USA) was analyzed using the SDS 7,300 software (Applied
Biosystems). GAPDH expression was used for normalization
(=dCT) and relative expression was calculated for each group
(2dCT) (42).
Statistical Analysis
As all data were distributed normally, a T-test was applied for
statistical analysis. P-values were considered significant ∗ at p ≤
0.05, ∗∗ at p ≤ 0.01, and ∗∗∗ at p ≤ 0.005. Where error bars are
shown, they represent the standard deviation for the respective
set of samples.
RESULTS
Chicken and Mammalian Pentraxin 3 Are
Homologs
As a first step toward the characterization of PTX3 in chickens,
we evaluated the extent of similarity between the PTX3 protein
sequences of chickens and other species. Thereby, we aimed
to acquire information on possible alterations in structure
of the proteins. The amino acid sequence of chPTX3 was
aligned with its counterparts in humans (Homo sapiens), mice
(Mus musculus), cattle (Bos taurus), swine (Sus scrofa), frogs
(Xenopus tropicalis), and zebra fish (Danio rerio). The alignment
(Figure S1) shows an extensive consensus in the pentraxin
domain and parts of the N-terminal domain, with an overall
sequence similarity of between 69 and 77 %, depending on the
species, over the 433 amino acids of the chPTX3 sequence.
Overall, 36 to 53 % of the amino acid residues were identical
(Figure 1A), verifying that chPTX3 is a close homolog of PTX3 in
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FIGURE 1 | Homology of PTX3 in various species. (A) Assessment of protein sequence similarity and identity of PTX3 amino acid sequences of various species,
obtained by pairwise alignment. The highest degree of similarity is observed among PTX3 sequences of mammals. The Gallus gallus PTX3 sequence (bold) is highly
similar to PTX3 of all examined species. (B) Phylogenetic analysis by Maximum Likelihood method. The tree with the highest log likelihood (−3,880.21) is shown. The
percentage of trees in which the associated taxa clustered together is shown next to the branches. The tree is drawn to scale, with branch lengths measured in the
number of substitutions per site.
other species. A phylogenetic analysis of PTX3 protein sequences
of the above mentioned species emphasizes the homology
and the higher degree of similarity between the mammalian
sequences as compared to the lower vertebrates (Figure 1B),
as seen in Figure 1A. A closer look at the alignment shows
two extended areas within the N-terminal domain in non-
mammalian species, which elongate these sequences by a total
of roughly 50 amino acids compared to humans and other
mammals. The chicken protein features insertions of 27 amino
acids between A100 and R101 and 18 amino acids between
R188 and A189 of the human protein, respectively (underlined
sequence parts in Figure S2). The existence of these elongated
sections in the chicken sequence was verified by sequencing
of thymus and spleen PCR products spanning this area
(Figure S2).
Analogous to the high overall sequence similarity, certain
characteristic features are similar between species. For example,
the eight amino acid pentraxin signature sequence (dotted
line) and a number of disulfide bond forming cysteine
residues (triangles) are conserved (Figure S1). Interestingly,
cysteine residue C103 in human PTX3 (upside-down triangle in
Figure S1) is not conserved in chickens, while all other cysteines
known to be structurally important, are. N-glycosylation sites
differ more widely between species. Whereas human, mouse,
and bovine PTX3 only have one predicted N-glycosylation site
each, and porcine PTX3 lacks these sites completely, the non-
mammalian species examined here all have two asparagine
residues with presumed N-glycosylation (compare asterisks in
Figure S1).
Recombinant chPTX3 Is a Polymeric
N-glycosylated Protein
To further analyze the structure of chPTX3, its sequence was
cloned into p3xFlag-Myc-CMV-25 and transfected intoHEK-293
cells to achieve expression of Flag-tagged chPTX3 (Figure 2A).
FIGURE 2 | Western blot analysis of PTX3-Flag resolved by SDS-PAGE
indicates that chPTX3 has a polymeric N-glycosylated structure. (A) Purified
chPTX3-Flag from cell culture supernatant under reducing conditions; shows
successful expression of the recombinant protein. (B) PTX3-Flag under
non-reducing (lane B1) and reducing (lane B2) conditions. ChPTX3 is
constituted as a polymer. (C) Reduced chPTX3-Flag before (lane C1) and after
(lane C2) N-deglycosylation. ChPTX3 contains N-glycosylated residues.
Western blot analysis under non-reducing (Figure 2B, lane 1)
and reducing conditions (Figure 2B, lane 2) revealed a polymeric
structure of PTX3 in chicken, as reported for mammalian PTX3
(43). The molecular weight (MW) of polymeric PTX3 could
not be determined exactly by means of Western blot analysis.
However, concluding from Figure 2B, lane 1, the protein is
likely to display a variable polymeric organization. The predicted
molecular weight of the monomer is 47353.41 Da. As Figure S1
shows, there are two predicted N-glycosylation sites in chPTX3.
Western blot analysis of chPTX3-Flag has also been carried out
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FIGURE 3 | Mean constitutive PTX3 expression in chicken tissue samples from RNA-seq dataset PRJEB12891. RNA-seq data was downloaded from the Short Read
Archieve (SRA) database for a total of 168 samples (21 tissues per bird) and blasted for PTX3 reads. Relative expression of PTX3 was assessed for each sample. Data
shown represent the mean value of the respective tissue; error bars indicate standard deviation from the mean. ChPTX3 expression pattern varies prominently
between tissues. The highest expression is observed in skin and kidney, the least in muscle, ovary, and spleen. Lymphoid tissue samples, except for spleen, express
moderate amounts of PTX3 in chickens. N = 8.
after PNGase F treatment, which eliminates N-glycosylations
(Figure 2C). A drop of the MW of monomeric PTX3 after N-
deglycosylation of ∼5 kDa was detected (Figure 2C, lane 2),
which indicates that at least one N-glycosylation site is present
within the protein.
Constitutive PTX3 Expression Differs
Widely Between Chicken Tissues
We next examined the constitutive expression pattern of PTX3
in various chicken tissues. A comprehensive study, executed
by The Roslin Institute in Edinburgh, UK, produced RNA-seq
libraries of 21 organ samples derived from eight 16 to 17 weeks
old healthy female J-line individuals each (NCBI BioProject
accession number: PRJEB12891). We found PTX3 transcripts
within these data. Figure 3 shows that PTX3 expression varies
prominently between native tissue samples. Muscular organs
like breast muscle, proventriculus, and heart show a very low
expression or no detectable expression at all. In duodenum and
ileum as well as in the glands appending to the intestine (pancreas
and liver) a moderate PTX3 expression is observed. This is
consistent with the PTX3 expression in other mesenchymal,
non-lymphoid organs examined (cerebellum, optic lobe, kidney,
trachea, lung, ovary, and thyroid), which also express PTX3 to
a moderate to high extent. The highest expression was observed
in skin samples. Interestingly, all lymphoid organs except for
the spleen, which apparently did not express PTX3 in any of
the eight examined samples, show moderate PTX3 expression
levels, as well. To verify these results, we conducted an RT-PCR
analysis on samples of lymphoid tissues of one chicken from our
facility. As RNA-seq data had suggested, no expression was found
in splenic tissue, while the Harderian gland, thymus, bursa, and
caecal tonsil did constitutively express considerable amounts of
chPTX3 (Figure 4).
Bioinformatics and Experimental
Approaches Prove Up-Regulation of
chPTX3 in Response to Viral and Bacterial
Stimuli
To further investigate the importance of chPTX3 as an acute
phase protein in chicken, we first analyzed a number of
RNA-seq data sets, generated within three different studies in
laboratories at the Henan Institute for Science and Technology,
the Iowa State University, and the Key Laboratory of Animal
Immunology of the Chinese Ministry of Agriculture to gain
a comprehensive overview. As Table 1 shows, PTX3 was up-
regulated in all three studies. At 1 and 3 dpi with Infectious Bursal
Disease Virus (IBDV), PTX3 was 12 and 20-fold up-regulated,
respectively, in samples from the bursa of Fabricius. The same
tissue up-regulated PTX3 after experimental APEC O1 infection.
Although up-regulation could already be shown at 1 dpi, it
only became significant at 5 dpi. Another interesting example
for a late occurring regulation is the infection with the Gallid
Alphaherpesvirus 2 (GaHV2). In this case, PTX3 expression in
spleens was slightly elevated at 7 and 14 dpi, but not at 3 dpi,
before it finally rose to a 29-fold increase at 21 dpi. The data
obtained from these studies suggest that PTX3 may play an
important role in experimentally induced inflammatory disease
in chickens.
Since RNA-seq data had shown a consistent PTX3 up-
regulation in a variety of infections, but with distinct regulation
patterns, we next analyzed the PTX3 response to a more
general inducer of inflammation. We therefore examined
data of an RNA-seq study assessing the response in splenic
tissue samples of Broiler and Fayoumi chickens to LPS from
Salmonella Typhimurium (44). Analysis revealed a significant
up-regulation in both breeds 3.5 h after LPS treatment compared
to mock-treated animals, with 95-fold up-regulation in broilers
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FIGURE 4 | Constitutive PTX3 expression in chicken lymphoid tissue samples,
analyzed by RT-PCR. RT-PCR analysis was used to amplify PTX3 transcripts in
various tissues. UV-visualization of a subsequent agarose gel electrophoresis
is shown. The (top) represents PTX3, the (bottom) shows GAPDH expression
in the same samples. RT-PCR underscores RNA-seq data analysis of chicken
lymphoid tissues. NTC, Non-template control.
TABLE 1 | PTX3 up-regulation as published in RNA-seq datasets.
Inflamatory stimulus Tissue Study ID Timepoint n Fold change
IBDV Bursa PRJNA369862 1 dpi 3 12
3 dpi 2 20
APEC Bursa PRJNA288323 5 dpi 4 4
GaHV2 Spleen PRJNA341964 21 dpi 1 29
(Figure 5A) and a 3.5-fold induction in the Fayoumi breed
(Figure 5B).
There are only few comprehensive studies on APPs in
chickens to date. To gain a thorough picture of the chicken
acute phase reaction, we injected LPS intravenously into White
Leghorn layer birds and isolatedmRNA from spleens 3 h later. An
mRNA library of each sample was analyzed by NGS. Processing
of NGS data resulted in a total of 175 differentially expressed
genes with a fold change of at least four between groups, of
which 133 were expressedmore intensely in LPS-treated chickens
compared to controls (data not shown). The 15most strongly up-
regulated genes are shown in Table 2. Of the 15 most strongly
up-regulated genes, 10 (Table 2 No. 3-6, 9-13, 15) are associated
with the GO-term “response to stimulus” (GO:0050896), which
is twice as many genes as would have been expected statistically.
Among the genes associated with GO:0050896, transcription of
the acute phase protein PTX3 (Table 2 No. 3) was up-regulated
most intensively with a fold-change of 108.
Since NGS data confirmed PTX3 to be strongly induced by
LPS in layer chickens, tissue samples of the same experiment
were subjected to qPCR analysis. The results are presented in
Figure 6 and confirm the RNA-seq findings for the spleens and
also show an up-regulation of chPTX3 in the livers of these
animals. The difference in normalized cut-off thresholds between
LPS-stimulated and control spleens and livers was 9.0 and 4.7,
respectively, which converts into fold changes of 507 in spleens
and 26 in livers.
To further validate our finding that bacterial components,
shown here for LPS (Table 2 and Figure 6), are able to strongly
induce PTX3 expression in chickens, the next step was to use
an experimental infection with APEC O1 and evaluate the PTX3
expression in spleens of infected and control chickens. We
therefore selected White Leghorn line 72 chickens, an inbred
chicken line reported to be relatively resistant to coinfection
with infectious bronchitis virus and APEC infection (45), and
injected a total of 51 birds with one of three different doses of
APEC O1 or with PBS as a control, respectively. Six infected
birds and three of the control group were euthanized at 14 h
(hpi), 3, and 7 days post infection (dpi) and spleen samples
were collected. Figure 7 shows, that PTX3 expression undergoes
a dose-dependent up-regulation at 14 hpi in these chickens.
Challenge with the low dose non-significantly amplifies PTX3
expression 9-fold, while significant up-regulation is observed
after intermediate dose (46-fold) and high dose (154-fold) APEC
O1 challenge. As Figure 8 shows, PTX3 expression correlates
significantly with bacterial load numbers in the spleen. In
agreement with the low numbers of viable bacteria recovered
from the spleen at 3 and 7 dpi (data not shown) there is
no significant difference in PTX3 expression between control
and infected birds at these time points, which underlines the
importance of chPTX3 as a marker for the acute phase of
infection.
DISCUSSION
The role of PTX3 in the innate immune system, where it acts as
a pattern recognition molecule and potent complement activator,
and the rapid change of its expression in the course of the acute
phase of infections have been studied intensely in mice and men
(2, 32, 46, 47). However, the expression, structure and function
of chicken PTX3 has previously been neglected. Our recent
microarray studies connected PTX3 to the acute phase reaction
in chickens for the first time (38). However, its annotation in the
chicken genome remained to be verified.
To address this question, we first examined the protein
encoded by the gene annotated as chPTX3 to assess the
sequence similarity to PTX3 of other vertebrates. With identical
amino acids representing 36 to 53% of the sequences and an
overall similarity of up to 77% with minor species-specific
variations, the chPTX3 sequence proved to be highly similar
to other PTX3 sequences. The pentraxin signature sequence
is an eight amino acid motif within the C-terminal so-
called pentraxin domain and is present in all members of
the pentraxin family (32). It is also conserved in chickens.
Interestingly, mammalian PTX3 sequences are more similar to
chicken PTX3 than are those of lower vertebrates like Xenopus
Frontiers in Immunology | www.frontiersin.org 7 February 2019 | Volume 10 | Article 124
Burkhardt et al. Chicken PTX3
FIGURE 5 | Analysis of RNA-seq data from study PRJNA340891 for PTX3 expression in spleens of LPS-treated chickens. RNA-seq data was downloaded from the
Short Read Archieve (SRA) database for a total of 32 samples and blasted for PTX3 reads. Relative expression of PTX3 was assessed for each sample. Data shown
represent the mean value of the respective group; error bars indicate standard deviation from the mean. PTX3 expression changes in response to a 3.5 h mock (PBS)
or LPS treatment in Broiler (A) and Fayoumi chickens (B). LPS enhances PTX3 expression in spleens of Broiler chickens to 95-fold and to 3.5-fold in Fayoumi
chickens. *p ≤ 0.05, **p ≤ 0.01. N = 8.
TABLE 2 | Fifteen most strongly up-regulated genes in chicken spleens in response to LPS treatment as determined by RNA-seq analysis.
No. Gene name Gene description Ensembl gene ID Fold change
1 IL4I1 Interleukin 4 induced 1 ENSGALG00000000081 227
2 AVD Avidin ENSGALG00000023622 125
3 PTX3 Pentraxin 3, long ENSGALG00000028284 108
4 ATF3 Activating transcription factor 3 ENSGALG00000025887 86
5 TNFRSF6B Tumor necrosis factor receptor superfamily, member 6b ENSGALG00000006106 79
6 ANGPTL4 Angiopoietin like 4 ENSGALG00000000619 71
7 ARSI Arylsulfatase family, member I ENSGALG00000005616 65
8 ST6GALNAC2 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-
acetylgalactosaminide alpha-2,6-sialyltransferase 2
ENSGALG00000001883 60
9 LHX1 LIM homeobox 1 ENSGALG00000005409 56
10 CA9 Carbonic anhydrase IX ENSGALG00000021340 54
11 SLCO4C1 Solute carrier organic anion transporter family member 4C1 ENSGALG00000026768 32
12 GCH1 GTP cyclohydrolase 1 ENSGALG00000012200 23
13 IL13RA2 Interleukin 13 receptor, alpha 2 ENSGALG00000020316 19
14 GVIN1 GTPase, very large interferon inducible 1 ENSGALG00000016556 18
15 OASL 2′-5′-Oligoadenylate synthetase-like ENSGALG00000013723 18
Shading indicates genes associated with GO term “response to stimulus”(GO:0050896).
tropicalis and Danio rerio. Closer examination of the sequences
nonetheless shows that there are some distinct features between
mammals and non-mammalian species examined here. One
notable difference is the deletion of significant parts of the
sequence in the course of mammalian evolution. These might
influence the quaternary structure and thereby the function of
chPTX3.
Human PTX3 has previously been shown to form asymmetric,
cyclic octamers (48) and cysteine residues are of major
importance to the formation of their critical intra- and interchain
disulfide bonds (43). By aligning PTX3 amino acid sequences of
human, mouse, cow, pig, chicken, frog, and zebra fish, we found
that most of the cysteine residues, which are in humans and mice
contributing to the formation of the polymeric structure of PTX3
(43, 48), are conserved in chickens. Contrarily, one of them, C103
in human PTX3, is not. C103 has been shown to confer the
organization of PTX3 protomers into either dimers or tetramers,
which then form the final octamer (48). Western blot analysis
of recombinant chPTX3 reveals a polymeric structure with a
prominent MW drop to ∼65 kDa after disulfide bond reduction
and thereby proves its polymeric structure. The polymer’s exact
MW and thereby its structural organization, however, remains
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FIGURE 6 | PTX3 expression in chicken spleen and liver after LPS treatment, as determined by qRT-PCR. Spleens and livers of a total of 12 chickens, of which 6 had
received LPS intravenously 3 h before scarification, were subjected to RNA extraction. cDNA samples were analyzed using qRT-PCR. Data shown represent the mean
value of the respective group; error bars indicate standard deviation from the mean. Mean 40-dCT in control (CTR) spleens is 26.6, and 35.6 in spleens of LPS-treated
chickens (LPS). CTR livers display a 40-dCT of 30.2, LPS livers of 34.9. These numbers convert to an expression fold change of 508 for spleens and 26 for livers. The
induction of chPTX3 in the LPS group is highly significant (***p ≤ 0.005) for both tissues. N = 6.
to be determined. These findings indicate a major divergence in
quaternary structure between mammalian and chicken PTX3.
Protein glycosylation was shown to be of significant functional
relevance in human PTX3. The terminal glycan of the PTX3 N-
glycosylation site at N220 is sialic acid. This molecule is one
of the main effectors of the binding characteristics of PTX3
to pathogens and mediators of immunological functions (46,
49). The sialic acid residue of N220 obscures ligand binding
sites on the protein surface of human PTX3, represented by
residues K214, E252, K255, and R332. Preventing excessive
C1q binding, PTX3 sialylation thus mediates down-regulation
of complement activation (46). The complement system is
activated in a highly potent manner only by deglycosylated
PTX3 (49). In addition, leukocyte trans-endothelial migration
is inhibited through occupation of P-selectin, which is essential
for the mediation of leukocyte rolling, by sialic acid residues on
the surface of human PTX3 (50). In contrast to its immune-
enhancing role, deglycosylation of PTX3 during influenza
infection abolishes its anti-viral activity. Only an intact sialic acid
residue on PTX3 is able to mimic hemagglutinin binding sites
on host cells and by that means act as a decoy receptor for the
virus (51). PTX3 deglycosylation in this case hence exacerbates
infection (35). The same mechanism probably applies to the
defense against other viruses with similar infection strategies
(52). Our analysis of PTX3 protein sequences revealed that the
number of N-glycosylation sites differs widely between species.
Like human PTX3, the mouse and bovine proteins also have one
predicted N-glycosylated asparagine residue (N-X-S/T, where X
can be any amino acid except for P). In addition, two of the four
amino acids interacting with the sialic acid residue at N220 in
humans are conserved in each of these species. In contrast, pig
PTX3 does not have any predicted N-glycosylation sites, which
may potentially contribute to their high susceptibility to a variety
of influenza virus infections (53). Most interestingly, prediction
of N-glycosylation sites for the three non-mammalian species
examined here resulted in two hits each, of which one is located
within the N-terminal and the C-terminal domain, respectively.
Here we prove the presence of at least one N-glycosylation site in
chPTX3 by a MW drop of deglycosylated compared to untreated
recombinant chPTX3. Due to the fact that the composition of
glycan substitutions is very variable, not only between species
but also in a tissue-specific manner (49), further analysis of these
structures will be necessary to assess whether only one or both
of the predicted N-glycosylation sites are indeed glycosylated
in chickens and if tissue-specific glycosylation might alter the
protein function in this species.
It has been published earlier that most APPs are mainly
synthesized and released by hepatocytes (54), but newer studies
indicate a more variable origin (55). In consensus with that,
mammalian PTX3 is expressed in a variety of cells under
inflammatory conditions and has been shown to be constitutively
expressed first and foremost in lymphatic endothelial cells (56).
We therefore next investigated the chPTX3 expression pattern
under non-inflammatory and inflammatory conditions. We first
searched public RNA-seq databases for studies on chicken tissues
and chose one especially comprehensive study. Interestingly,
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FIGURE 7 | Expression changes of PTX3 in spleens of line 72 chickens at 14 hpi, 3 dpi, and 7 dpi with low, intermediate or high doses of APEC O1, or mock injection,
determined by qRT-PCR. Mean 40-dCT values for controls (white bars) and low (7.3 × 104 CFU; light gray bars), intermediate (1.1 × 106 CFU; medium gray bars),
and high (8.8 × 106 CFU; dark gray bars) doses were 21.6, 24.7, 27.1, and 28.9, respectively, at 14 hpi. These numbers depict a non-significant expression fold
change of 9 between control and low, a very significant fold change of 46 for intermediate (**p ≤ 0.01), and a highly significant fold change of 154 for high dose APEC
O1 (***p ≤ 0.005). Expression changes for APEC-infected birds relative to controls at 3 dpi and 7 dpi were not significant. ChPTX3 expression changes in a
dose-dependent manner at 14 h post infection. Data shown represent the mean value of the respective group; error bars indicate standard deviation from the mean.
N = 3 PBS controls, N = 6 APEC O1 low and intermediate dose inoculated birds, N = 5 APEC O1 high dose inoculated birds.
most analyzed chicken tissues constitutively expressed PTX3.
Exceptions were muscular organs (breast muscle, proventriculus,
and heart muscle), ovary and spleen. In contrast, skin and
kidney showed the most prominent constitutive expression.
PTX3 expression has previously been shown to be constitutive
in human kidney, as well (57), whereas skin samples have, to the
best of our knowledge, not been analyzed for constitutive PTX3
expression in mammals so far. Interestingly, Doni and coworkers
recently reported a strong association of PTX3 with the process
of wound healing in mice (47). As the skin forms the outer body
barrier (58) and the kidney is one of the main detoxification
organs (59), these tissues can in vivo probably hardly ever be
considered “unstimulated” and their strong expression of an
inflammation-responsive molecule is no surprise.
Highly surprising, on the other hand, was the finding that
the main lymphoid organ of birds (who lack lymph nodes),
the spleen, did not considerably express chPTX3 in any of the
eight sampled individuals. This finding in chickens is contrary
to mammals, where lymphatic endothelia show a prominent
constitutive expression of PTX3 (56). The lack of constitutive
PTX3 expression in this immunologically highly relevant tissue
points to active regulatory mechanisms. As recently shown
in human primary cells and cell lines, PTX3 expression is
regulated by three upstream regulatory elements, of which one
is also highly conserved in chickens. It was shown furthermore,
that in colorectal cancer cells, PTX3 is silenced by epigenetic
modifications within these regions, that are, among other factors,
induced by a high activity of STAT3 in these cells (60). STAT3 or
another regulator of immune functions might be responsible for
depression of PTX3 in unstimulated chicken spleens to prevent
overstimulation of the immune system. Complete elucidation
of the non-redundant immunological functions of the avian
spleen, however, remains yet to be achieved and might help
to explain PTX3 regulation. Other major lymphoid organs
in chickens, including the Harderian gland, thymus, bursa of
Fabricius and the caecal tonsil, did constitutively express PTX3.
This is consistent with the findings in mammalian lymphatic
endothelia (56). To verify the RNA-seq data for lymphoid tissues,
we performed an RT-PCR analysis of chicken samples from
our facility and were able to confirm the RNA-seq results by
demonstrating the absence of constitutive chPTX3 expression
in spleen, but strong signals in the other four lymphoid tissue
samples.
As a next step, we aimed to characterize PTX3 expression
changes in response to inflammation. We analyzed RNA-seq
data from various studies addressing the acute phase response in
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FIGURE 8 | Correlation of PTX3 expression and number of viable bacteria in chicken spleens at 14 hpi after low, intermediate and high dose APEC O1 infection. PTX3
expression correlates significantly (p = 0.0313) with the amount of viable bacteria inoculated in the tissue. N = 17. CFU/g, colony forming units per gram of splenic
tissue.
chickens and thereby detected a PTX3 up-regulation in a number
of highly relevant viral and bacterial diseases, including IBDV,
APEC, and GaHV2, the pathogen inducing Marek’s Disease.
Analysis of the dataset drawn from an experimental infection
with 108 CFU APEC O1 (61) resulted in a PTX3 expression
increase of only 4-fold between controls and diseased birds,
occurring at 5 dpi. On the other hand, LPS induced a 96-
fold and a 3.5-fold expression change for Broiler and Fayoumi
chickens, respectively, in another study of which we examined
the RNA-seq data (44). This prominent difference in PTX3
induction demanded further investigation of the overall chicken
acute phase reaction. Our next approach hence was to perform
an RNA-seq analysis on spleen samples taken from White
Leghorn Layer chickens from our facility, which had been LPS-
or mock-treated for 3 h. As would have been expected after
LPS-treatment, the majority of the most strongly up-regulated
genes cluster to the GO term “response to stimulus.” Supporting
our thesis that PTX3 is an important acute phase protein in
chickens, the PTX3 gene was up-regulated 108-fold in LPS-
treated chickens and showed up on position 3 of the most
highly up-regulated genes. Narrowing the list down to only those
genes associated with “response to stimulus,” it even was the
most strongly regulated gene. A subsequent qPCR analysis of
spleen and liver samples of six LPS- and mock-treated chickens
verified the results obtained by NGS. The 15 most strongly
down-regulated genes, in contrast, do not clearly cluster to any
immune response-associated GO term in particular, but are
mostly linked to processes concerned with tissue homeostasis
(data not shown). The down-regulation seen here is exemplary
for the fact, that under inflammatory conditions, tissue and
endothelial integrity are impaired (62, 63). Interestingly, none
of the genes encoding proteins that are considered classical
APPs in mammals, e.g., CRP and SAP, show up in this analysis
even though they have repeatedly been described in birds (19,
64). Nor did we detect any known chicken APPs, like SAA,
ceruloplasmin, ovotransferrin or α1-acid glycoprotein, to be
differentially regulated in this experiment. These data prove the
induction of PTX3 in genetically diverse chickens such as White
Leghorn layers, Broilers, and Fayoumi chickens and indicate,
that PTX3 might play an important role as a major APP in
chickens.
The next step after proving that chicken PTX3 is inducible
by an inflammation-inducing but non-infectious agonist in vivo
was to perform a comprehensive kinetic study using the White
Leghorn inbred line 72, which has been shown to be relatively
resistant to coinfection with infectious bronchitis virus and
APEC (45). We thereby aimed to assess if PTX3 is an appropriate
marker of subclinical disease and whether its expression would
correlate with the severity of infection. We compared PTX3
expression changes in spleens triggered by three different doses
of APEC O1 at three early time points, 14 hpi, 3 dpi and 7
dpi. It is shown here that all infected chickens significantly
amplify their PTX3 expression, but only at 14 hpi. The PTX3
expression increases in a challenge dose-dependent manner.
Expression fold changes are 9, 46, and 154 for low, intermediate
and high dose APEC O1-treatment, respectively. The changes
in intermediate and high dose expression, as compared to
controls, are of high significance. PTX3 expression in splenic
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tissue correlates significantly with the bacterial burden in the
same tissue samples, which makes PTX3 a valuable indicator
of infection severity. Interestingly, PTX3 levels do not differ
between controls and infected chickens at the later time points,
when bacterial burdens are decreasing toward zero again. The
differential PTX3 expression between challenge doses and its
correlation with the number of viable bacteria in the respective
samples establish chPTX3 as a potential tool for the diagnosis of
inflammatory disease and represent indicators of even subclinical
pathologic conditions.
In conclusion, the study presented here shows that PTX3 is
of major interest concerning the chicken acute phase reaction.
We showed that the chPTX3 protein, regardless of a high
overall sequence similarity, differs from the well-described
mammalian PTX3 by structural aspects, which are very likely
to convey differential functional characteristics. Furthermore, we
succeeded in expressing recombinant chPTX3, which enables
us to generate specific monoclonal antibodies. Detection of the
PTX3 protein in serum and other biological samples will thereby
be rendered possible. The results presented here build a solid
base for further studies on chPTX3 ligands, binding properties,
and association to immunological pathways in the future. We
furthermore prove here that PTX3 is expressed in a large
variety of chicken tissues and that the chicken’s main lymphoid
organ, the spleen, does not, like the other lymphoid tissues
in chickens and mammals, constitutively express PTX3, but
rigorously responds to inflammatory stimulation. Inflammation,
however, induces a stimulus- and infection dose-dependent
PTX3 response in spleen and other tissues on mRNA level. Based
upon the first insights on chPTX3 presented here, further studies
may provide evidence for its eligibility as a general marker for the
acute phase of inflammation and thereby support diagnostics and
disease control for a progressive poultry industry.
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